Baudax Historical Balance Sheet
BXRX Stock | USD 0.01 0.0003 2.91% |
Trend analysis of Baudax BioInc balance sheet accounts such as Other Current Liab of 13.6 M, Total Current Liabilities of 17.4 M or Other Liab of 9.1 M provides information on Baudax BioInc's total assets, liabilities, and equity, which is the actual value of Baudax BioInc to its prevalent stockholders. By breaking down trends over time using Baudax BioInc balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Baudax BioInc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Baudax BioInc is a good buy for the upcoming year.
Baudax |
About Baudax Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Baudax BioInc at a specified time, usually calculated after every quarter, six months, or one year. Baudax BioInc Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Baudax BioInc and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Baudax currently owns. An asset can also be divided into two categories, current and non-current.
Baudax BioInc Balance Sheet Chart
Baudax BioInc Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Baudax BioInc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Baudax BioInc's Other Current Liabilities is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 400.4 K in 2024, whereas Total Assets are likely to drop slightly above 8.6 M in 2024. Add Fundamental
Total Assets
Total assets refers to the total amount of Baudax BioInc assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Baudax BioInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Baudax BioInc balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Baudax BioInc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Baudax BioInc's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Baudax BioInc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.At this time, Baudax BioInc's Other Current Liabilities is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 400.4 K in 2024, whereas Total Assets are likely to drop slightly above 8.6 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 12.0M | 11.9M | 10.7M | 13.6M | Total Assets | 53.3M | 10.0M | 9.0M | 8.6M |
Baudax BioInc balance sheet Correlations
Click cells to compare fundamentals
Baudax BioInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Baudax BioInc balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 54.2M | 68.7M | 53.3M | 10.0M | 9.0M | 8.6M | |
Other Current Liab | 7.1M | 13.5M | 12.0M | 11.9M | 10.7M | 13.6M | |
Total Current Liabilities | 7.7M | 18.1M | 15.6M | 21.5M | 19.3M | 17.4M | |
Total Stockholder Equity | (16.7M) | (14.8M) | 13.2M | (24.2M) | (27.9M) | (29.3M) | |
Other Liab | 62.8M | 56.6M | 18.1M | 10.7M | 9.6M | 9.1M | |
Net Tangible Assets | (45.2M) | (41.2M) | (10.6M) | (26.4M) | (30.3M) | (31.8M) | |
Property Plant And Equipment Net | 5.6M | 5.6M | 5.0M | 704K | 633.6K | 601.9K | |
Accounts Payable | 271K | 3.7M | 1.5M | 3.9M | 3.5M | 2.6M | |
Non Current Assets Total | 34.1M | 32.0M | 29.8M | 3.7M | 3.3M | 3.2M | |
Non Currrent Assets Other | 34.1M | 583K | 963K | 854K | 768.6K | 730.2K | |
Liabilities And Stockholders Equity | 54.2M | 68.7M | 53.3M | 10.0M | 9.0M | 8.6M | |
Non Current Liabilities Total | 63.2M | 65.4M | 24.4M | 12.8M | 11.5M | 11.0M | |
Other Current Assets | 2.4M | 3.3M | 2.1M | 753K | 677.7K | 643.8K | |
Other Stockholder Equity | 20.2M | 98.3M | 144.3M | 166.6M | 191.6M | 201.2M | |
Total Liab | 70.9M | 83.5M | 40.1M | 34.3M | 30.8M | 57.0M | |
Property Plant And Equipment Gross | 5.6M | 5.6M | 6.5M | 472K | 542.8K | 515.7K | |
Total Current Assets | 20.1M | 36.7M | 23.5M | 6.3M | 7.3M | 6.9M | |
Non Current Liabilities Other | 62.8M | 56.9M | 18.1M | 11.3M | 10.2M | 9.7M | |
Net Working Capital | 12.4M | 18.6M | 7.8M | (15.1M) | (17.4M) | (16.5M) | |
Common Stock | 94K | 487K | 983K | 16K | 18.4K | 19.3K | |
Property Plant Equipment | 5.6M | 5.1M | 5.0M | 704K | 633.6K | 601.9K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Baudax BioInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Baudax BioInc's short interest history, or implied volatility extrapolated from Baudax BioInc options trading.
Pair Trading with Baudax BioInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Baudax BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baudax BioInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Baudax Stock
0.75 | EVOK | Evoke Pharma | PairCorr |
0.61 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
Moving against Baudax Stock
0.78 | HCWB | HCW Biologics | PairCorr |
0.78 | KRYS | Krystal Biotech Financial Report 13th of May 2024 | PairCorr |
0.74 | VKTX | Viking Therapeutics | PairCorr |
0.73 | OGN | Organon | PairCorr |
0.65 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Baudax BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Baudax BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Baudax BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Baudax BioInc to buy it.
The correlation of Baudax BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Baudax BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Baudax BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Baudax BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Baudax Stock analysis
When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.13) | Revenue Per Share 0.318 | Quarterly Revenue Growth (0.23) | Return On Assets (1.15) | Return On Equity (47.04) |
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.